baber/WOPTO huggingface dataset:
Patent CA-2477588-A1 (CA)
Title: Flip-flop with transmission gate in master latch
Inventor: FULKERSON DAVID E
IPC: H03K3/012
Filed: 2003-02-25
Abstract: A method and apparatus for storing data in a master flip flop, comprising in combination receiving a clock signal having a first and second state, storing a master data state in a master storage device having a master storage input and a master storage output, storing a master complement data state in a master complement storage device having a master complement storage input and a master storage complement output, receiving a data input signal by a transmission gate, receiving a complement data input signal by a complement transmission gate, overriding the master storage complement output with the data input signal when the clock is in the first state, overriding the master storage output with the complement data input signal when the clock is in the first state, disconnecting the master storage complement output from the data input signal when the clock is in the second state, and disconnecting the master storage output from the complement data input signal when the clock is in the second state. The set-up time for the transmission gate is less than two transistor gate delays.
Patent CA-2478168-A1 (CA)
Inventor: PARRY HADYN ST PIERRE
IPC: B01D11/02
Filed: 2003-03-04
Abstract: A method for monitoring the quality of a herbal medicine comprising the steps of: (a) providing a sample of the herbal medicine (b) extracting the sample with a polar solvent to produce a polar extract (c) subjecting the polar extract to ion-exchange chromatography to produce an extract enriched in ionic compounds (d) chromatographically fractionating the enriched extract to yield one or more polar fractions (e) characterizing the polar fractions.
Patent CA-2478426-A1 (CA)
Inventor: HERRIDGE DAVID B
IPC: A43B21/28
Filed: 2003-03-05
Abstract: A shock absorbing bladder for use in the sole (3) of an article of footwear is disclosed. The bladder includes a plurality of inflated chambers at different pressure levels. The bladder includes a first sealed chamber (15, 18) formed of a barrier material. The first chamber contains a fluid at a first fluid pressure. A second sealed chamber (13, 14) also forms part of the bladder. The second chamber is formed of a second barrier material and contains an inflation fluid at a second fluid pressure that is greater than said first fluid pressure. The second chamber is operatively coupled to the first chamber so that the inflation fluid from the second chamber moves into the first chamber to replenish fluid leaving the first chamber.
Patent CA-2479898-A1 (CA)
Inventor: NISHIMURA CHIHIRO
IPC: C07F9/568
Filed: 2003-03-24
Abstract: A novel .alpha.-amino-N-(diaminophosphinyl)lactam derivative represented by the general formula (I) [wherein, for example, A represents hydrogen or a substituent such as lower alkyl; W, X, Y, and Z each independently represent s hydrogen or a substituent such as lower alkyl, aryl, arylacyl, or arylaminocarbonyl; and Q represents -(CH2)n- (n is 0 to 3)] or a salt of the derivative; and a therapeutic agent and preventive for marrow inhibition, a therapeutic agent for infectious diseases, a leukocyte enhancer, and a dipeptidyl peptidase IV inhibitor which each contains the derivative or salt as an active ingredient.
Patent CA-2480614-A1 (CA)
Inventor: LORENZ GISELA
IPC: A01N37/52
Filed: 2003-04-02
Abstract: The invention relates to a fungicidal mixture containing (1) a benzamidoxime derivative of formula (I), whereby the substituent and the index are defined as follows: R represents hydrogen, halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy or C1-C4 haloalkoxy, n represents 1, 2 or 3; and at least one additional strobilurin derivative, selected from (2) a trifloxystrobin of formula (II), or (3) a picoxystrobin of formula (III), or (4) a pyraclostrobin of formula (IV), or (5) a strobilurin derivative of formula (V), or (6) a strobilurin derivative of formula (VI), or (7) a dimoxystrobin of formula (VII), or (8) a kresoxim methyl of formula (VIII), or (9) an azoxystrobin of formula (IX), or (10) a strobilurin derivative of formula (X) in a synergistically active quantity.
Patent CA-2480627-A1 (CA)
Title: Method and apparatus for the regasification of lng onboard a carrier
Inventor: NIERENBERG ALAN B
IPC: F17C9/02
Filed: 2002-03-29
Abstract: An LNG carrier having onboard regasification capability that includes a primary source of heat (21) for regasifying the LNG (24) is disclosed.  Further, the LNG carrier includes at least one secondary source of heat for regasifying the LNG, a vaporizer (23), an intermediate fluid, and a pump (22) that circulates said intermediate fluid through said vaporizer and said primary and secondary sources of heat.
Patent CA-2481339-A1 (CA)
Title: Methods for targeting quadruplex dna
Inventor: SIDDIQUI-JAIN ADAM
IPC: C12Q1/68
Filed: 2003-04-04
Abstract: Among the different intrastrand quadruplex structures that can arise from duplex DNA, it has been discovered that a chair conformation is biologically significant. Also, it has been determined that certain mutations in quadruplex forming nucleotide sequences destabilize quadruplex structure and are associated with cancer. Thus, provided herein are quadruplex~destabilized nucleic acid acids, cancer diagnostics and prognostics, methods for using the cancer diagnostics and prognostics to prevent and/or treat cancer, nucleic acid therapeutics that target quadruplex-destabilized nucleotide sequences and methods, methods for identifying compounds that modulate the biological activity of a native quadruplex DNA in a chair conformation, and methods for modulating the biological activity of a native quadruplex DNA with a compound identified by the methods described herein.
Patent CA-2483026-A1 (CA)
Inventor: HEIL ROSS F
IPC: F25D17/04
Filed: 2003-04-18
Abstract: A filter (106) for absorbing ethylene gas and moisture and emitting carbon dioxide that can be removably coupled to a container (100). The container (100) can have vent openings to allow air to circulate to prevent excess condensation, or the container can be any type of flexible, semirigid, or rigid produce container such as a plastic bag, a refrigerator or a typical plastic container. The contents of the filter (106) are in vapor contact with the internal environment of the container such that it can absorb ethylene gas and moisture in the container and release carbon dioxide into the container to retard the ripening process of the produce stored in the container.
Patent CA-2485205-A1 (CA)
Inventor: MONTOYA DORA C
IPC: A41D20/00
Filed: 2004-11-16
Abstract: During the operation of a computer mouse or keyboard, the wrist of the operator often rubs and bends causing muscle fatigue and damage to tendons and nerves. This invention is designed to help alleviate such problems by providing support around the wrist without sacrificing freedom of movement. The invention consists of a foam ring, with no moving or metal parts, covered in a cotton cloth.      The structure fits snugly around the wrist of the user.
Patent CA-2489886-A1 (CA)
Title: Wire protection and storage grommet
Inventor: ARTHUR RICHARD L
IPC: H02G3/04
Filed: 1999-02-18
Abstract: A wire protection grommet (40) for installation in a wire pull opening (31) extending between a preset (24) and a cell (18) of a cellular raceway (10) comprises a housing (39) configured for mounting in the wire pull opening (31), the housing (39) defining a passage (44) extending between the preset (24) and the raceway cell (18), the passage (44) defining a wire pull strain relief (45). The grommet is weighted for self-orientation within the wire pull opening (31).
Patent CA-2490571-A1 (CA)
Title: Pyrazoloisoquinoline derivatives for inhibiting nfkappab-inducing kinase (nik)
Inventor: FLOHR STEFANIE
IPC: C07D471/04
Filed: 2003-06-20
Abstract: The invention relates to compounds of formula (I), which are suitable for producing medicaments for the prophylaxis and treatment of diseases, the progression of which involves an increased activity of NIK.
Patent CA-2491565-A1 (CA)
Title: Catalyseurs de metal oxyde et procede de production de gaz de synthese
Inventor: WANG DAXIANG
IPC: C01B3/38
Filed: 2003-06-30
Abstract: La présente invention concerne généralement des catalyseurs comprenant au moins un métal actif oxydé; au moins un lanthanide; et un support réfractaire. Le métal actif est sélectionné dans le groupe constitué par rhodium, ruthénium, rhénium, platine, palladium, iridium, et osmium. L'invention concerne en particulier des catalyseurs pouvant démarrer et maintenir efficacement l'oxydation partielle d'hydrocarbures légers, de préférence le méthane, relativement à un mélange de produits comprenant un monoxyde de carbone et de l'hydrogène, par exemple du gaz de synthèse. L'invention concerne en outre un procédé de production d'un catalyseur de gaz de synthèse supporté comprenant un métal oxydé et au moins un lanthanide.
Patent CA-2491792-A1 (CA)
Title: Navigated stemmed orthopaedic implant inserter
Inventor: MCGINLEY SHAWN E
IPC: A61B19/00
Filed: 2005-01-10
Abstract: A navigated stemmed orthopaedic implant inserter and method are presented for use with a surgical navigation system.
Patent CA-2494593-A1 (CA)
Inventor: HOFFMANN MICHAEL GERHARD
IPC: C07D413/14
Filed: 2003-07-14
Abstract: La présente invention concerne des pyridines et des pyrimidines substituées par 4-trifluorométhylpyrazolyle de formule (I) et leur utilisation en tant qu'herbicides. Dans la formule générale (I), R?1¿, R?2¿, R?3¿ et R?4¿ sont différents radicaux, A est un radical aromatique ou hétéroaromatique, et Z est un atome d'azote ou de carbone.
Patent CA-2494993-A1 (CA)
Inventor: KUTYAVIN IGOR V
IPC: C12N/
Filed: 2003-08-20
Abstract: La présente invention concerne un procédé permettant la détection et/ou le génotypage d'acides nucléiques en utilisant la spécificité d'un endonucléase AP (Apurinique / Apyrimidinique). L'invention permet également un nouveau procédé d'amplification d'acides nucléiques.
Patent CA-2497047-A1 (CA)
Title: Adzymes and uses thereof
Inventor: BAYNES BRIAN
IPC: A61K47/48
Filed: 2003-08-27
Abstract: Disclosed is a family of novel protein constructs, useful as drugs and for other purposes, termed "adzymes," comprising an address moiety and a catalyt ic domain. In some types of disclosed adzymes, the address binds with a binding site on or in functional proximity to a targeted biomolecule, e.g., an extracellular targeted biomolecule, and is disposed adjacent the catalytic domain so that its affinity serves to confer anew specificity to the catalyt ic domain by increasing the effective local concentration of the target in the vicinity of the catalytic domain. The present invention also provides pharmaceutical compositions comprising these adzymes, methods of making adzymes, DNA's encoding adzymes or parts thereof, and methods of using adzymes, such as for treating human subjects suffering from a disease, such as a disease associated with a soluble or membrane bound molecule, e.g., an allergic or inflammatory disease.
Patent CA-2503292-A1 (CA)
Inventor: ENG KEVIN
IPC: G16B20/00
Filed: 2003-11-21
Abstract: La présente invention concerne des procédés et des systèmes informatiques utilisés pour comparer des biomolécules entre échantillons biologiques. Dans ce contexte, on effectue des relevés de spectrométrie de masse sur des biomolécules prises dans deux échantillons ou plus. Ces relevés sont ensuite traités et analysés au moyen des méthodes décrites à des fins de comparabilité. Cette technologie est dite de <= mise en correspondance de constellations >=/Constellation Mapping (CM). Les résultats ainsi obtenus, ou cartes de constellation, peuvent servir à comparer la quantité 'abondance de biomolécules dans des échantillons et, en temps réel, être utilisés pour la sélection de biomolécules en abondance variable pour LC/MS-MS ultérieures (chromatiographie liquide/spectrométrie de masse en tandem).
Patent CA-2504379-A1 (CA)
Inventor: BERNSTEIN ERIC F
IPC: A01N43/54
Filed: 2003-10-29
Abstract: Procédés servant à empêcher le photovieillissement et les coups de soleil par application localisée d'une composition contenant caféine ou un composé dont la structure est analogue à celle de la caféine. Composition pharmaceutique contenant caféine ou un composé dont la structure est similaire à celle de la caféine afin d'empêcher le photovieilllissement et les coups de soleil.
Patent CA-2505487-A1 (CA)
Title: Levobupivacaine and its use as an anaesthetic in obstetrics
Inventor: GRISTWOOD ROBERT WILLIAM
IPC: A61P23/00
Filed: 1994-10-13
Abstract: The present invention is directed to use of levobupivacaine or a salt thereof for use as an anaesthetic in obstetrics. In one embodiment, levobupivacaine is in at least 90% enantiomeric excess with respect to dexbupivacaine. Levobupivacaine is useful as an anaesthetic in a human patient having or disposed to depressed myocardial contractility.
Patent CA-2507374-A1 (CA)
Inventor: KLASSEN GERHARD D
IPC: G06Q10/00
Filed: 2003-02-07
Abstract: In a computer system, a system, method and computer program product for pre-selecting a folder for a current message. The system, method and computer program product involve (a) providing a folder pre-selection cache having n configurable entries, n being a predetermined positive integer greater than one, each configurable entry being configured to include an associated pre-selection criterion for matching with the current message, and an associated folder identification for identifying an associated folder in the plurality of folders; (b) for at least one entry in the folder pre-selection cache, comparing a comparison criterion, obtained from the current message, with the associated pre-selection criterion to determine a matching entry in the folder pre-selection cache; and, (c) pre-selecting the folder identified by the associated folder identification of the matching entry when the message comparison module determines the matching entry in the folder pre-selection cache.
Patent CA-2507529-A1 (CA)
Inventor: DUNK CRAIG A
IPC: H04L69/40
Filed: 2002-12-20
Abstract: A front end of an IPv6 communication network includes a network entry point device (114) and a plurality of tunnel servers (118) which facilitate the communication of user information between a host computer (108) of an IPv4 communication network (110) and an IPv6 wireless communication device (130).  The network entry point device is configured to direct a tunnel request from the host computer to a selected tunnel server, which establishes a tunnel connection with the host computer. For the tunnel connection, the data packets can be encapsulated based on SSH, PPTP, L2TP, IPSec or PP standards. The tunnel server facilitates the communication of user information between the host and the wireless device through the tunnel connection. The tunnel server also performs a dynamic routing protocol (DRP). In accordance with the DRP, the tunnel server updates a local routing table to reflect the newly established tunnel connection and broadcasts updated routing table information to the other tunner servers and at least one router (126). In another technical aspect, a back end of the IPv6 wireless device when it operates in an IPv4 wireless communication network. This can be achieved ba a router (126) encapsulating packets to the temporary Ipv6 - address assigned to a wireless device (130) using a temporary IPv4 - address.
Patent CA-2508655-A1 (CA)
Inventor: KUEHNE REINHARD
IPC: G06F12/00
Filed: 2003-12-01
Abstract: The invention relates to a memory system which is configured with a pluralit y of memory controllers (SCx), disposed in parallel on a clocked bus (B), and memory chips (Fx) associated with the respective memory controllers (SCx). T he system communicates via the bus (B) with a host system (HS) by means of operational memory commands using logical memory sector numbers. The inventi ve system is characterized in that for any memory operation requested by the ho st system (HS) the memory controller (SCx) affected with respect to a range of logical memory sector numbers (SCx) takes over the bus for communication wit h the host system (HS) by means of arbitration.
Patent CA-2510909-A1 (CA)
Title: Method and apparatus for beer dispensing systems
Inventor: HASKAYNE PAUL
IPC: B67D1/08
Filed: 2005-06-23
Abstract: A multiple-temperature beer dispensing system (10) (and related methods) is provided in which a plurality of beer sources (12) are coupled to a plurality of taps (16). Heat exchangers (18) may be disposed between one or more of the beer sources (12) and one or more of the taps (16). Beer temperatures may be controlled with a controller (30), sensors (32) and valves (34). Also provided is system (50) that allows a single tap (16n) to dispense beer at more than one temperature. Also provided is a controlled temperature storage chamber (100) and a tube bundle (70).
Patent CA-2512161-A1 (CA)
Inventor: HU FANG
IPC: A61K35/765
Filed: 2004-01-28
Abstract: The present invention relates to compositions and methods for ablating tumor cells in a subject having at least one tumor site. More specifically, the method comprises contacting the tumor cells in at least one tumor with a lytic agent in vivo, under lytic conditions, forming a treated tumor; and applying a sufficient in vivo stimulus to the treated tumor forming a stimulated tumor.  Compositions and methods are included for shrinking a local tumor or a distal metastatic tumor, or both in a subject. In a preferred embodiment, the method for shrinking a tumor in a subject comprises: contacting a stimulated tumor cells in vivo with a lytic agent. The stimulus directed toward the tumor cells is capable of increasing the level of chaperone proteins in the tumor cells.  The combination of lytic agents and tumor cell stimulus leads to shrinkage of the tumors that were treated directly, wherein the stimulus is either applied simultaneously or sequentially. Moreover, distal or metastatic tumors that were not-treated directly are also decreased by introducing a lytic agents into a stimulated tumor cells in a first-tumor ("the treated tumor" or "the local tumor"). The preferred method steps that include introduction of a lytic agent and stimulation of the tumor cells is repeated in order to maximize the tumor shrinkage effects.
Patent CA-2513730-A1 (CA)
Inventor: MASLOV ALEXANDER
IPC: C12Q1/68
Filed: 2004-01-16
Abstract: This invention provides a method for identification and characterization of genes expressed during differentiation of cells. Cell lineage specific genes are identified in embryonic stem cells lines by unique vectors constructed to permit rapid characterization of expressed genes.
Patent CA-2513806-A1 (CA)
Title: Bobinoir a courses decouplees pour fibres thermoplastiques
Inventor: NAULET CHRISTOPHE
IPC: B65H57/28
Filed: 2004-01-22
Abstract: Bobinoir (1) essentiellement constitué d'un châssis (2), ce châssis comportant au moins une broche (6, 7) adaptée pour supporter au moins un gâteau, ladite broche (6, 7) étant mobile en rotation autour d'un premier axe sensiblement perpendiculaire au diamètre du gâteau, et au moins un dispositif (8) de positionnement et de guidage adapté pour positionner et guider au moins un fil sur la broche (6, 7) en rotation, caractérisé en ce que la broche (6, 7) est montée mobile linéairement suivant le premier axe de rotation.
Patent CA-2514595-A1 (CA)
Inventor: SANTARPIO RICHARD J
IPC: H04L47/43
Filed: 2004-02-04
Abstract: A wideband cable modem system increases available bandwidth of a single channel by encoding a data stream into wideband packets. The wideband packets are associated with a logical wideband channel that extends over multiple physical downstream cable channels.
Patent CA-2515210-A1 (CA)
Title: Combined use of ribavirin and interferon beta in demyelinating diseases
Inventor: DE LUCA GIAMPIERO
IPC: A61K45/06
Filed: 2004-02-24
Abstract: The present invention is in the field of neurological disorders. It relates to the use of a compound of formula (I) in combination with an interferon (IFN) for the manufacture of a medicament for treatment and/or prevention of a demyelinating disease. In particular, it relates to the use of a combination of Ribaririn and IFN-beta for treatment and/or prevention of a demyelinating disease, such as multiple sclerosis.
Patent CA-2515368-A1 (CA)
Inventor: OBICI SILVANA
IPC: A61K39/00
Filed: 2004-02-12
Abstract: Methods of reducing food intake and glucose production in a mammal, or restoring hepatic autoregulation are provided. The methods involve increasing long-chain fatty acyl-Co-A (LC-CoA) levels in the hypothalamus, or stimulating efferent fibers in the hepatic branch of the vagus nerve. Also provided are methods of increasing food intake and glucose production in a mammal. The methods involve decreasing long-chain fatty acyl-Co-A (LC-CoA) levels in the hypothalamus of the mammal.
Patent CA-2518464-A1 (CA)
Title: Reducing discomfort caused by electrical stimulation
Inventor: RIEHL MARK EDWARD
IPC: A61N2/00
Filed: 2004-03-05
Abstract: The invention is directed to a method for reducing discomfort caused by transcutaneous stimulation. The method includes providing transcutaneous stimulation, reducing the transcutaneous stimulation at a first location, and substantially maintaining the transcutaneous stimulation at a second location.  The transcutaneous stimulation may be created by electric and/or magnetic fields. The first location may be relatively proximate to the cutaneous surface and may comprise tissue, nerve and muscle. The second location may be relatively deeper than the first location and include, for example, brain tissue that requires the transcutaneous stimulation for treatment purposes.  The invention further may include locating a conductor (105) on a treatment area and/or a transcutaneous stimulation device (100) relative to the first location. The method may include adjusting how much the transcutaneous stimulation is reduced at the first location.
Patent CA-2518639-A1 (CA)
Inventor: RITTNER ROLAND
IPC: H01K1/16
Filed: 2005-09-07
Abstract: The invention relates to an electric incandescent lamp having power supply wires for at least one incandescent filament, at least one power supply wire being provided with a role in which an outgoing filament line of the at least one incandescent filament is fixed.
Patent CA-2519367-A1 (CA)
Inventor: YARBOROUGH CODY L
IPC: A61M5/00
Filed: 2004-03-16
Abstract: A process for lyophilizing a solution (50) of an active agent in a container (19) is provided. Solution of active agent is deposited into a container, the container is covered with a covering plate (60) and placed inside a lyophilizing apparatus. Lyophilization can be conducted to dryness by radiation, convection or both. Also provided is a device made by this process, an active agent-plastic administration device (e.g., a syringe (20)), containing an active agent in the form of lyophilized cake, and an array of such administration devices.
Patent CA-2523645-A1 (CA)
Inventor: DONOVAN MAURA G
IPC: G01N21/85
Filed: 2004-04-09
Abstract: Activation of an enzyme in a bodily fluid is detected based on the amount of cleavage of a substrate for the enzyme. The substrate is tagged with two fluorescent dyes - a donor and an acceptor. The tagged substrate is presented to the bodily fluid. A device emits energy at a first wavelength into the bodily fluid, and detects energy at second and third wavelengths emitted by the dyes in response to the energy at the first wavelength. Prior to enzymatic cleavage of the substrate, the acceptor emits energy at the third wavelength in response to energy at the second wavelength received through fluorescent resonant energy transfer (FRET) from the donor. After enzymatic cleavage of the substrate, the donor emits energy at the second wavelength. The device can determine the concentration of activated enzyme within the bodily fluid based on the relative intensities of energy at the second and third wavelengths.